Daily Brief United States: Natural Gas, Copper, Paragon 28 Inc, Cirrus Logic, Gold, Columbia Sportswear Co, Ethereum, DXC Technology Co, CEL-SCI , Globe Life and more

• Debate surrounding potential increase in Russian pipeline gas to Europe, with uncertainty of timing and magnitude of flows
• Russia, Ukraine, Europe, and the US all have vested interests in potential negotiations for increased pipeline gas flows
• Impact on European natural gas balance and global gas balance if increased Russian pipeline flows were to manifest, with current base case price forecast for TTF market in 2025 and 2026 without embedding increase in Russian natural gas flows

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

• The outlook for copper in the near term is positive, but the market interest in copper may mean higher prices
• Investing in copper may be expensive due to high demand and M&A activity in the sector
• Finding a pure play copper company of significant scale on the ASX may be challenging, with considerations of China’s impact on copper demand and production levels in mind.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

• Paragon 28 is being acquired by Zimmer Biomet for $13/share plus a non-transferable CVR, with potential payout.
• Allakos is undergoing a strategic review, trading at net cash, with potential value in NOLs and reverse merger.
• Copper Property CTL Trust is liquidating, marketing 121 retail properties leased to JC Penney, with 30%+ NAV upside.

• Cirrus Logic recently reported its financial performance for the third quarter of the fiscal year 2025, revealing both opportunities and challenges.
• The company announced revenues of $555.7 million, surpassing the upper limit of its guidance range due to stronger-than-anticipated demand in the smartphone sector.
• However, this quarter represented a 10% decline in sales year-over-year, attributed largely to a decrease in smartphone volumes and adjustments in the fiscal calendar.

• Long gold has been a winning strategy over the last two calendar years. Gold futures has clocked a 125% increase since start of 2019 until now.
• Gold has seen its strongest rally yet over the last two years, breaking through previous all-time highs with minimal retracement.
• GLD ETF has delivered a 7.4% price returns over the last month and an 8% upside YTD in 2025 so far.

• Columbia Sportswear Company’s fourth quarter and full-year financial performance for 2024 presented a mixed picture rooted in market dynamics and strategic initiatives.
• On the earnings call, the company leadership, including CEO Tim Boyle, highlighted achievements in inventory management, cost savings, and international market growth, while acknowledging challenges faced in North American market conditions.
• Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

• Ethereum leads in tokenization, but Solana and Sui are gaining traction with high-speed trading and alternative L1 adoption. Institutional multi-chain strategies may drive further competition.
• Ethereum’s L2s enhance scalability, but fee revenue is diversifying as Alt-L1s grow. Base shows how L2s can leverage Ethereum’s security while competing ecosystems challenge its dominance.
• TradFi is embracing blockchain, with stablecoins and tokenization set to expand. BlackRock’s BUIDL fund on Ethereum highlights its role as the preferred settlement layer for institutional finance.

• DXC Technology showed promising third-quarter fiscal year 2025 results, driven by effective operational changes and strategic initiatives.
• The company reported revenue, adjusted EBIT margin, and non-GAAP EPS above its forecast expectations.
• Revenue declined by 4.2% year-over-year on an organic basis, while the adjusted EBIT margin increased to 8.9%, reflecting a year-over-year expansion.

• CEL-SCI is developing two platforms: Multikine and LEAPS.
• Multikine has completed a Phase 3 trial for head and neck cancer while LEAPS is conducting preclinical studies for RA, Pandemic Flu and breast cancer.
• In June 2021, CEL-SCI reported selected data from its IT-MATTERS trial demonstrating a benefit in the low PD-L1, non-chemotherapy population.

• Globe Life Inc. faced a share price decline and negative report from Fuzzy Panda in April 2024 due to concerns about bad agents and a kickback scheme
• Despite SEC inquiry and potential cyber-attack, Globe Life showed strong performance in third quarter
• Company facing challenges such as whistleblower lawsuit dismissal and extortion by hackers, but outlook remains positive with stock trading at a discount to long-term levels

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.